Phase one — securing the foundation — is complete. Filings current across every obligation, gross profit growing, Adjusted EBITDA positive — and on July 15, 2026, the cease trade order was fully revoked, with trading resumption on the CSE expected this month.
Canadian Securities Exchange
Primary listing
United States
US market
Frankfurt Stock Exchange
European market
| Class of Securities | Outstanding | Exercise Price |
|---|---|---|
| Common shares | 179,661,148 | — |
| Net profit shares (management performance shares) | 65,031,826 | — |
| Warrants | 10,000,000 | $0.12 |
| Insider, management & employee ownership (fully diluted) | 49.4% | — |
As presented in the Company's Q3 2026 investor materials. Full details available in continuous disclosure filings on SEDAR+.
| Audited (CAD) | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $53,161,556 | $54,337,795 | $60,356,959 |
| Cost of sales | $46,290,687 | $48,420,002 | $53,634,294 |
| Gross profit | $6,870,869 | $5,917,793 | $6,722,665 |
| Cash (as of most recent audited statements) | $6,613,534 | $4,642,700 | $4,276,888 |
Q1 2026 Adjusted EBITDA(1) — up 49% year-over-year.
Q1 2026 gross margin, up from 11.5% in Q1 2025.
Blended rate on $23.5M senior debt after cutting subordinated obligations from $14M at 15% to $11M at 10%.
Long-term platform potential management sees at 20% gross margins through the three-phase plan.(2)
(1) Non-IFRS measure — see the Q1 2026 news release for reconciliation. (2) Forward-looking statement reflecting management's long-term ambition; see disclaimer below. Actual results may differ materially.
Under a cease trade order, Eat Well rebuilt its financial reporting infrastructure from the ground up — and on July 15, 2026, secured a full revocation of the order.
Audited consolidated financial statements and MD&A filed for fiscal years 2023 and 2024.
Unaudited quarterly condensed interim financial statements filed for all four quarters of fiscal 2024.
First on-time annual audit in several years, completing all outstanding annual disclosure obligations.
Fiscal 2025 quarterly filings completed and application submitted to the BCSC and OSC for a full revocation of the cease trade order and resumption of trading on the CSE.
First quarter reported on a normal course timeline: Adjusted EBITDA of $790,313 and gross margin of 15.7%.
The BCSC and OSC issued a full revocation of the CTO originally issued on July 7, 2023 — announced in the Company's July 16 news release.
The Company anticipates that trading of its common shares on the Canadian Securities Exchange will recommence as soon as practicable.
High-interest debt refinanced, non-core assets divested — including the sale of the Company's equity interest in PataFoods for US$7 million — filings brought fully current, and the cease trade order revoked. Complete.
Deploy targeted capital to optimize core facilities, launch high-margin, value-added product lines, and significantly boost EBITDA and net income.
With ~50 years in the sector, the team knows exactly what to acquire and when — unlocking scalable assets and driving toward a large-scale platform.
Audited annual financial statements, interim filings and MD&A for fiscal 2023–2025 and all subsequent periods.
Open SEDAR+ → GovernanceAudit, Compensation and Governance Committee charters adopted by the Board on June 2, 2026.
View governance → PresentationThe Company's current investor presentation — operations, strategy, financial highlights and capitalization.
Download the PDF →Join Eat Well's investor mailing list — or reach investor relations directly at ir@eatwellgroup.com / +1 (604) 340-4187.